Drug biggie Sun Pharma, which has topped India’s pharma retail market for years, has now become the leader in prescriptions, bolstered by an increase in field force and a sharper focus on core therapies.For the first time, Sun Pharma secured the top position by doctor prescriptions, toppling long-standing Mankind Pharma, according to market research firm SMSRC (moving annual total for August 2022).“We continue to outperform the average industry growth, which has led to an increase in our overall market share. Though Sun Pharma is a specialty company with limited coverage among GPs, we have now become number one in terms of prescription share. Sun has a leadership position in a dozen therapies,” the company’s CEO (India business), Kirti Ganorkar, told TOI.